The Chief Executive Officer of the Food and Drugs Authority (FDA), Dr. Delese Darko, has emphasized that the acceptance of part payment of administrative fines from companies in violation of regulations does not compromise the authority’s regulatory mandate.
She addressed Journalists on Tuesday on concerns surrounding a recent case involving Lamens Investments Africa Limited, which was fined GH¢100,000 for the unauthorized repackaging of Moshosho white Doubled Sortex Indian Rice.
Dr. Darko stated that the FDA remains committed to enforcing compliance while ensuring public health and safety.
“Accepting part payment does not in any way undermine the FDA’s regulatory mandate. It allows enforcement actions to proceed without delay while ensuring outstanding obligations are met,” she said.
The fine was imposed after FDA officers discovered unauthorized repackaging activities at a National Food Buffer Stock Company (NAFCO) warehouse in Kumasi on December 20, 2023.
Following a police-led inspection, the premises were sealed, and regulatory measures were initiated in line with the Public Health Act, 2012 (Act 851).
After further investigations, the FDA reviewed its earlier decision and acknowledged that the rice’s original Best Before End (BBE) date of December 2023 allowed for a regulated shelf-life extension if proper conditions were met.
A confirmatory report from the manufacturer, Satyam Balajee Rice Ind Pvt Ltd., and Bureau Veritas India supported an extension of the BBE date to December 2024, citing proper storage conditions.
However, the FDA granted a provisional extension only until April 30, 2024, contingent upon repeat testing for moisture, mould, and yeast levels to ensure continued safety and quality.
Dr. Darko reaffirmed the FDA’s dedication to safeguarding public health, highlighting its rigorous inspection and testing procedures, ISO-certified laboratory standards, and adherence to international best practices.
“The FDA’s actions are guided by transparency and professionalism. Our commitment to protecting public health remains steadfast, and we are open to audits by qualified local and international bodies to validate our processes,” she added.
The FDA also assured the public that the Moshosho rice in question was confirmed wholesome before its release for distribution, reinforcing its mission to ensure food safety across Ghana.
Story by: Joshua Kwabena Smith
Comments